Business
After a Disappointing Experience, the Drugmakers Behind Controversial Alzheimer's Therapy ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'After a disappointing experience, the drugmakers behind controversial Alzheimer's therapy Aduhelm are not giving up and have another treatment on the way. ...'
After a disappointing experience, the drugmakers behind controversial Alzheimer's therapy Aduhelm are not giving up and have another treatment on the way. https://t.co/xAeWkpAXWt— Bloomberg (@business) July 18, 2022
(The above story first appeared on LatestLY on Jul 18, 2022 07:21 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
